SCHEMBL28006751

SCHEMBL28006751

O=C1c2c(O)cc(O)cc2OC(c2cc(O)c(O)c(O)c2)C1(O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 4/20 0.55
TDP1 Q9NUW8 2/20 0.55
SOST Q9BQB4 2/20 0.53
SYNJ2 O15056 1/20 0.53
APP P05067 1/20 0.53
CYP3A4 P08684 5/20 0.42
CYP1A2 P05177 4/20 0.42
HSD17B10 Q99714 4/20 0.42
CYP19A1 P11511 4/20 0.42
MAPT P10636 3/20 0.42
CYP1A1 P04798 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP1B1 Q16678 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 2/20 0.42
GAA P10253 2/20 0.42
ALOX15 P16050 2/20 0.42
MAPK1 P28482 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15544677 0.86 RECQL (0.55) RECQLTDP1SOSTSYNJ2APP
SCHEMBL31237635 0.86 RECQL (0.55) RECQLTDP1SOSTSYNJ2APP
SCHEMBL19248891 0.86 RECQL (0.52) RECQLTDP1SOSTSYNJ2APP
SCHEMBL6068882 0.86 CYP3A4 (0.53) RECQLTDP1SOSTCYP3A4CYP1A2
SCHEMBL5597840 0.84 CYP3A4 (0.54) RECQLTDP1SOSTSYNJ2APP
SCHEMBL5146606 0.79 POLB (0.60) RECQLTDP1CYP3A4CYP1A2HSD17B10
SCHEMBL31238336 0.79 RECQL (0.56) RECQLTDP1SOSTCYP3A4CYP1A2
SCHEMBL30754201 0.72 CYP3A4 (0.51) RECQLTDP1SOSTCYP3A4CYP1A2
SCHEMBL28763278 0.71 CYP1A2 (0.51) RECQLTDP1SOSTCYP3A4CYP1A2
SCHEMBL23044063 0.71 RECQL (1.00) RECQLTDP1SOSTSYNJ2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131193-A1 SULFONAMIDE-CONTAINING 4-(N-METHYL) AMINOPIPERIDINE MYRICETIN DERIVATIVES, PREPARATION METHOD AND APPLICATION GUIZHOU UNIVERSITY (CN) 2023-04-27 US disclosed
CN-111728965-A Application of compound in preparation of antiviral drug 华中科技大学同济医学院附属同济医院 2020-10-02 CN disclosed
CN-110183430-B 4- (N-methyl) aminopiperidine myricetin derivative containing sulfamide, preparation method and application 贵州大学 2020-06-05 CN disclosed
CN-110638809-A Composition with whitening effect 浙江万里学院 2020-01-03 CN disclosed
CN-109267088-A A kind of method of dihydromyricetin dehydrogenation 湖南中茂生物科技有限公司 2019-01-25 CN disclosed
CN-109053666-A A kind of extracting method of dihydromyricetin 湖南中茂生物科技有限公司 2018-12-21 CN disclosed
CN-104496955-A Five different crystal substances of dihydromyricetin AFFILIATED TONGJI HOSPITAL OF TONGJI MEDICAL COLLE 2015-04-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131193-A1 SULFONAMIDE-CONTAINING 4-(N-METHYL) AMINOPIPERIDINE MYRICETIN DERIVATIVES, PREPARATION METHOD AND APPLICATION NISCH, SMYD2, NSD2 RECQL 3051/4885TDP1 3144/4885SOST 2478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.